Based on the current market data and analyst ratings, FHN stock shows mixed signals. The stock is currently trading at $22.08 with moderate technical strength (RSI at 62.26) suggesting neither overbought nor oversold conditions.
Recent analyst ratings from January 2025 indicate a cautiously optimistic outlook. Major firms including Wells Fargo, JP Morgan, and B of A Securities have maintained their ratings with price targets ranging from $22 to $25, suggesting potential upside of 2-16%. B of A Securities is notably bullish with a "Strong Buy" rating and $25 target.
The company recently declared a quarterly cash dividend of $0.15 per share, payable on April 1, 2025, demonstrating continued commitment to shareholder returns. Q4 2024 earnings exceeded expectations with adjusted EPS of $0.43 versus estimates of $0.38, benefiting from increased net interest income and reduced expenses.
Given the current price level near Wells Fargo's target of $22 but below other analysts' higher targets, combined with stable fundamentals and positive earnings momentum, holding FHN stock appears more prudent than selling at current levels.